The past 5 years have seen the review of the National Medicine Policy, and three important reports, the 2020 House of Representatives Committee ‘The New Frontier – delivering better health for all Australians’, the 2024 Enhance HTA: An Enhanced Consumer Engagement Process in Australian Health Technology Assessment’ and the 2024 ‘Accelerating Access to the best medicines for Australians and now and into the future’. Collectively their recommendations intend to achieve wide ranging changes to improve timely, appropriate and equitable access to medicines particularly but not exclusively through changes to HTA. In responding to the reports, the Australian Government wants to understand the specifics of what is involved in implementation, where relevant the likelihood that different options for change will produce the desired improvements in access and the financial and other impacts. The system changes involved are complicated, in some cases may need to be undertaken sequentially and will take time. I will outline the progress the Implementation Advisory Group has made in developing advice on these questions.